title: Cigarette smoke increases gastric ulcer size in part by an angiotensin II-mediated mechanism in rats.
abstract: To assess the mechanism of the effect of cigarette smoke on ulcer disease we employed a rat model in which cigarette smoke increases the size of acetic acid-induced gastric ulcer and decreases the hyperemia at the ulcer margin. We postulate that cigarette smoke increases angiotensin II (a vasoconstrictor) in ulcer tissue. Since direct measurement of angiotensin II in small tissue samples is problematic, we compared the messenger ribonucleic acid (mRNA) for its precursors (angiotensinogen and renin) in ulcer and normal gastric tissue. We also evaluated the effect of enalapril, which blocks the conversion of angiotensin I to angiotensin II on ulcer size. In the ulcer tissue, cigarette smoke produced a significant increase in mRNA for angiotensinogen but not for renin. Enalapril decreased the size of the gastric ulcer in rats exposed to cigarette smoke. The data support the possibility that in ulcer tissue cigarette smoke stimulates an angiotensin II-mediated mechanism, which may in part be responsible for the impairment of ulcer margin hyperemia and aggravation of ulcer size.
authors.affiliation: Gastroenterology Laboratory, Sepulveda and West Los Angeles Veterans Administration Medical Center California, 91343, USA.
authors.forename: K
authors.initials: K
authors.lastname: Seno
authors.forename: J H
authors.initials: JH
authors.lastname: Zhu
authors.forename: J D
authors.initials: JD
authors.lastname: Barrett
authors.forename: P
authors.initials: P
authors.lastname: Eggena
authors.forename: O U
authors.initials: OU
authors.lastname: Scremin
authors.forename: K
authors.initials: K
authors.lastname: Lam
authors.forename: J W
authors.initials: JW
authors.lastname: Leung
authors.forename: F W
authors.initials: FW
authors.lastname: Leung
mesh_terms: D000804:Angiotensin II / Q000378:metabolism / Q000502:physiology*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology; D000818:Animals; D004656:Enalapril / Q000494:pharmacology; D015151:Immunoblotting; D008297:Male; D010982:Platelet-Derived Growth Factor / Q000032:analysis; D012333:RNA, Messenger / Q000032:analysis; D051381:Rats; D017207:Rats, Sprague-Dawley; D012083:Renin / Q000032:analysis; D012907:Smoking / Q000009:adverse effects*; D013002:Somatomedins / Q000032:analysis; D013276:Stomach Ulcer / Q000139:chemically induced / Q000378:metabolism / Q000473:pathology*; D016212:Transforming Growth Factor beta / Q000032:analysis
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D010982:Platelet-Derived Growth Factor; D012333:RNA, Messenger; D013002:Somatomedins; D016212:Transforming Growth Factor beta; D000804:Angiotensin II; D004656:Enalapril; D012083:Renin